AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis

BioFactors

Volumn 10, Issue 2-3, 1999, Pages 211-217

  Sherman, David R ^a   Mdluli, Khisimuzi ^b   Hickey, Mark J ^a   Barry III, Clifton E ^b   Stover, C Kendall ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CUMENE HYDROPEROXIDE; ISONIAZID; PEROXIDASE; THIOREDOXIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CONFERENCE PAPER; DRUG DETOXIFICATION; DRUG SENSITIVITY; GENE MUTATION; GENE OVEREXPRESSION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0032693096     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520100219     Document Type: Conference Paper

References (29)

1. B.R. Bloom and P.M. Small, The evolving relation between humans and Mycobacterium tuberculosis, New England Journal of Medicine 338 (1998), 677-678.
2. H.Z. Chae, S.J. Chung and S.G. Rhee, Thioredoxin-dependent peroxide reductase from yeast, Journal of Biological Chemistry 269 (1994), 27 670-27 678.
3. H.Z. Chae, K. Robison, L.B. Poole, G. Church, G. Storz and S.G. Rhee, Cloning and sequencing of thiol-specific antioxidant from mammalian brain: Alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes, Procedings of the National Academy of Sciences USA 91 (1994) 7017-7021.
4. M.F. Christman, R.W. Morgan, F.S. Jacobson and B.N. Ames, Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium, Cell 41 (1985), 753-762.
5. S.T. Cole, R. Brosch, J. Parkhill, T. Garnier, G. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, S. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead and B.G. Barrell, Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature 393 (1998), 537-544.
6. V. Deretic, W. Philipp, S. Dhandayuthapani, M.H. Mudd R. Curci, T. Garbe, B. Heym, L. Via and S.T. Cole, Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid, Molecular Microbiology 17 (1995), 889-900.
7. S. Dhandayuthapani, Y. Zhang, M.H. Mudd and V. Deretic, Oxidative stress response and its role in sensitivity to isonazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis, Journal of Bacteriology 178 (1996), 3641-3649.
8. B. Halliwell and J.M.C. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochemical Journal 219 (1984), 1-9.
9. B. Heym, P.M. Alzari, N. Honore and S.T. Cole, Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis, Molecular Microbiology 15 (1995), 235-45.
10. B. Heym, E. Stavropoulos, N. Honore, P. Domenech, B. Saint-Joanis, T. Wilson, D. Collins, M.J. Colston and S.T. Cole, Effects of overexpression of the alkylhydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis, Infection and Immunity 65 (1997), 1395-1401.
11. K. Johnsson and P.G. Schultz, Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis, Journal of the American Chemical Society 116 (1995), 7425-7426.
12. S. Kaufman and J. van Embden, Tuberculosis: a neglected disease strikes back, Trends in Microbiology 1 (1993), 2-5.
13. C.L. Kelley, D.A. Rouse and S.L. Morris, Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy 41 (1997) 2057-2058.
14. G. Middlebrook, Isoniazid-resistance and catalase activity of the tubercle bacilli, Annual Review of Tuberculosis 69 (1954), 471-472.
15. J.M. Musser, Antimicrobial agent resistance in mycobacteria: molecular genetic insights, Clinical Microbiology Review 8 (1995), 496-514.
16. J.L. Rosner, Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid, Antimicrobial Agents and Chemotherapy 37 (1993), 2251-2253.
17. J.L. Rosner and G. Storz, Effects of peroxides on susceptibilities of Escherichia coli and Mycobacterium smegmatis to isoniazid, Antimicrobial Agents and Chemotherapy 38 (1994), 1829-1833.
18. D.A. Rouse, J.A. DeVito, Z. Li, H. Byer and S.L. Morris, Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance, Molecular Microbiology 22 (1996), 583-592.
19. D.R. Sherman, K. Mdluli, M. Hickey, T. Arain, S. Morris, C.E. Barry and C.K. Stover, Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis, Science 272 (1996), 1641-1643.
20. D.R. Sherman, P. Sabo, M. Hickey, T. Arain, G. Maharias, Y. Yuan, C.E. Barry and C.K. Stover, Disperate responses to oxidative stress in saprophytic and pathogenic mycobacteria, Proceedings of the National Academy of Sciences USA 92 (1995), 6625-6629.
21. H.A. Shoeb, B.U.J. Bowman, A.C. Ottollenghi and A.J. Merola, Enzymatic and nonenzymatic superoxide-generating reaction of isoniazid, Antimicrobial Agents and Chemotherapy 27 (1985), 408-412.
22. H. Sies, Biochemistry of oxidative stress, Agnew Chemistry International, English Edition 25 (1986), 1058-1071.
23. G. Storz and L.A. Tartaglia, OxyR: a regulator of antioxidant genes, Journal of Nutrition 122 (1992), 627-630.
24. K. Takayama, L. Wang and H.L. David, Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth and viability of Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy 2 (1973), 29-35.
25. B. Wieles, S. Nagai, H.G. Wiker, M. Harboe and T.H.M. Ottenhoff, Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis, Infection and Immunity 63 (1995), 4946-8494.
26. T.M. Wilson, G. de Lisle and D.M. Collins, Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis, Molecular Microbiology 15 (1995), 1009-1015.
27. T.M. Wilson and D.M. Collins, ahpC, a gene involved in isoniazid resistance of the Mycobaterium tuberculosis complex, Molecular Microbiology 19 (1996), 1025-1034.
28. Y. Yuan, R. Lee, G.S. Besra, J.T. Belisle and C.E. Barry III, Identification of a gene involved in the biosynthesis of cyclopropanated mycolic in Mycobacterium tuberculosis, Proceedings of the National Academy of Sciences USA 92 (1995), 6630-6634.
29. Y. Zhang, B. Heym, B. Allen, D. Young and S.T. Cole, The catalse-peroxidise gene and isoniazid resistance of Mycobacterium tuberculosis, Nature 358 (1992), 591-593.